about
Idiopathic Inflammatory Myopathies: Clinical Approach and ManagementTargeting protein homeostasis in sporadic inclusion body myositis.Autoimmune neuromuscular disordersIncidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis.An overview of polymyositis and dermatomyositis.A randomized, pilot trial of etanercept in dermatomyositis.Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients.Clinical Implications and Hospital Outcome of Immune-Mediated Myositis in Horses.Persisting weakness after withdrawal of a statin.Electrodiagnostic evaluation of myopathies.Neurogenic changes in the upper airway of obstructive sleep apnoea.Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.Rapidly progressive myositis as the sole manifestation of a concurrent gastric carcinomaLong-term efficacy of intravenously administered immunoglobulin in a case of polymyositis with limited application of steroid therapy.Necrotizing myopathy: clinicoserologic associations.[Severe dysphagia and erythrodermia in a 59-year-old man].Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan.Medical costs and health-care resource use in patients with inflammatory myopathies in an insured population.Anti-Neutrophil Cytoplasmic Antibody-associated Vasculitis (AAV) Restricted to the Limbs: A Case Report.[Myositides: What is the current situation?].Associations between apparent diffusion coefficient and electromyography parameters in myositis-A preliminary study.MRI-Guided Biopsy as a Tool for Diagnosis and Research of Muscle Disorders
P2860
Q26744705-1F81EF55-636B-45A0-8ADC-602EB134B1CCQ27324564-5559552E-DA9F-4314-9063-1093EBB14A9CQ28261039-EBFCE9C7-2BFD-4E7D-BBBB-7310E8E7F513Q34306432-C946FBA5-EA69-4E4C-B96A-4438B215F693Q34667765-BFD64E95-6EFF-4F3E-A5E3-28E05FD6C19DQ35206687-241998AF-7A73-4FB1-A611-CDBE1B576B3EQ35900966-BCC78C75-BDAD-4484-8388-B2E89B874922Q37601859-73A0C231-CEA6-4B72-B313-75EC6390AD84Q37704222-CA66A8A2-06F9-46BA-BD9B-8C0570023DAAQ38062074-78D977C7-D58F-4AE2-AD5F-54602A09A881Q38363900-2BEBF2D1-F146-477A-ACCB-69E62B587A0CQ38619882-45284A27-7AC8-48C5-971F-2E4807211367Q41859802-7BADF616-97F9-45E8-8FC0-F4EB7D4C553CQ43103428-B272A863-F49A-4942-AFC8-2603EF556B53Q43440724-C73EDAAF-C260-46A7-A9E6-602FDD7FEBF3Q45001327-7A6B5D2A-7BD0-4FBB-9E0D-0AF3AEE682E4Q46107385-36F1910F-22ED-4C6F-8E1A-4BC02B4AA6D2Q46527397-50B164E4-57F8-44F6-ADBA-F6F9EEF43288Q49567268-84BECBD1-CC53-47BE-8CC1-7C4D1876DDACQ54258621-89E886E9-7DD8-4BFD-AD53-C81C6D63E3ADQ55525301-BCDAC527-F942-4C8B-8B0B-D64274EB7BB8Q58803312-50A84B50-61F6-4D52-B15B-8BA8AA1F3659
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluation and treatment of inflammatory myopathies.
@en
Evaluation and treatment of inflammatory myopathies.
@nl
type
label
Evaluation and treatment of inflammatory myopathies.
@en
Evaluation and treatment of inflammatory myopathies.
@nl
prefLabel
Evaluation and treatment of inflammatory myopathies.
@en
Evaluation and treatment of inflammatory myopathies.
@nl
P356
P1476
Evaluation and treatment of inflammatory myopathies.
@en
P2093
P304
P356
10.1136/JNNP.2008.169375
P407
P577
2009-10-01T00:00:00Z